Save the Date: on Tuesday, May 19, 2026, the Stuart & Molly Sloan Precision Oncology Institute will be hosting a symposium to explore new approaches to traditionally undruggable targets. This symposium will bring together thought leaders and discuss the latest breakthroughs, challenges, and future directions in turning previously elusive disease drivers into viable therapeutic opportunities for cancer and other diseases. Following talks, all attendees are invited to meet the speakers and enjoy a selection of food and beverages at a reception.
The Drugging the Undruggable Symposium is co-hosted by Behnam Nabet, PhD, Assistant Professor, Human Biology Division.
Registration will open in early January 2026. All are welcomed and invited to attend. We hope you'll join us!
1100 Fairview Ave N, Seattle, WA 98109